NO20081010L - Farmasoytisk forbindelse inneholdende kornet pantoprazol - Google Patents

Farmasoytisk forbindelse inneholdende kornet pantoprazol

Info

Publication number
NO20081010L
NO20081010L NO20081010A NO20081010A NO20081010L NO 20081010 L NO20081010 L NO 20081010L NO 20081010 A NO20081010 A NO 20081010A NO 20081010 A NO20081010 A NO 20081010A NO 20081010 L NO20081010 L NO 20081010L
Authority
NO
Norway
Prior art keywords
pantoprazole
compound containing
pharmaceutical compound
containing granular
particle size
Prior art date
Application number
NO20081010A
Other languages
English (en)
Norwegian (no)
Inventor
Franc Vrecer
Andrejka Kramar
Urska Turk
Andrej Ferlan
Lidia Cernosa
Gregor Ritlop
Majanca Breznik
Original Assignee
Krka Tovarna Zdravil Dd Novo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd Novo M filed Critical Krka Tovarna Zdravil Dd Novo M
Publication of NO20081010L publication Critical patent/NO20081010L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20081010A 2005-07-29 2008-02-26 Farmasoytisk forbindelse inneholdende kornet pantoprazol NO20081010L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05016555A EP1747776A1 (en) 2005-07-29 2005-07-29 Pharmaceutical composition comprising granular pantoprazole
PCT/EP2006/064824 WO2007014928A1 (en) 2005-07-29 2006-07-29 Pharmaceutical composition comprising granular pantoprazole

Publications (1)

Publication Number Publication Date
NO20081010L true NO20081010L (no) 2008-04-16

Family

ID=35149583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081010A NO20081010L (no) 2005-07-29 2008-02-26 Farmasoytisk forbindelse inneholdende kornet pantoprazol

Country Status (9)

Country Link
EP (2) EP1747776A1 (pl)
EA (1) EA014187B1 (pl)
HR (1) HRP20170591T1 (pl)
NO (1) NO20081010L (pl)
PL (1) PL1909761T3 (pl)
PT (1) PT1909761T (pl)
SI (1) SI1909761T1 (pl)
UA (1) UA86541C2 (pl)
WO (1) WO2007014928A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20070253A1 (it) * 2007-11-09 2009-05-10 Valpharma Internat S P A Formulazioni farmaceutiche per la somministrazione di ipp.
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
AU2013204533B2 (en) * 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
ATE303809T1 (de) * 1997-12-08 2005-09-15 Altana Pharma Ag Orale verabreichungsform enthaltend einen protonenpumpeninhbitor (z.b. pantoprazole)
AU1998200A (en) * 1999-01-07 2000-07-24 Elan Corporation, Plc Multiparticulate oral dosage forms
US7357943B2 (en) * 2000-12-07 2008-04-15 Nycomed Gmbh Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
HU227317B1 (en) 2003-11-25 2011-03-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Enteric coated tablet containing pantoprazole

Also Published As

Publication number Publication date
PL1909761T3 (pl) 2017-08-31
HRP20170591T1 (hr) 2017-06-30
EP1747776A1 (en) 2007-01-31
EP1909761B1 (en) 2017-01-18
UA86541C2 (ru) 2009-04-27
WO2007014928A1 (en) 2007-02-08
PT1909761T (pt) 2017-04-13
EA014187B1 (ru) 2010-10-29
EA200800443A1 (ru) 2008-06-30
SI1909761T1 (sl) 2017-07-31
EP1909761A1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
NO20081010L (no) Farmasoytisk forbindelse inneholdende kornet pantoprazol
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
DK1852428T3 (da) 4-Cyclopropyl-1,2,3-thiadiazolforbindelse, landbrugs- og gartneriplantesygdomskontrolmiddelog fremgangsmåde til anvendelse deraf
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
NO20074256L (no) Fremstilling av stopte legemer fra ligocellulosebaserte finpartiklete materialer
BRPI0910182A2 (pt) composto de fórmula (i), composição farmacêutica, método de tratamento de um distúrbio e uso de um composto"
MA28626B1 (fr) Forme cristalline delta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
DK1776010T3 (da) Fremgangsmåde til fremstilling af vandige aktivstofsammensætninger af aktivstoffer, som er tungt oplöselige i vand
ATE517621T1 (de) Verwendung von ampk-aktivierenden imidazol- derivaten, herstellungsverfahren dafür und diese enthaltende pharmazeutische zusammensetzungen
FR2891827B1 (fr) Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
NO20053214L (no) Fremgangsmate for fremstilling av pulveraktige sammensetninger av fettloselige forbindelser.
WO2006092409A3 (en) Fast-release microcapsule products
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
CL2007003061A1 (es) Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
UA86914C2 (ru) Пестицидная композиция, способ ее получения и применение для борьбы с вредителями, живущими в почве и на поверхности почвы
HRP20171908T1 (hr) Farmaceutski pripravak koji sadrži ligande dopamin receptora i metode liječenja koje koriste ligande dopamin receptora
NO20062082L (no) Pellets inneholdende venlafaksinhydroklorid
WO2010059534A3 (en) Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
ATE514415T1 (de) Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide
WO2007024744A3 (en) Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
IS8128A (is) Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða
BRPI0415566A (pt) agente aglutinante para matriz de solidificação
WO2007047431A3 (en) Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors
HRP20180077T1 (hr) Farmaceutski sastav koji sadrži statin
ATE517644T1 (de) Mikrogelpartikel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application